0001415889-23-011251.txt : 20230718 0001415889-23-011251.hdr.sgml : 20230718 20230718215929 ACCESSION NUMBER: 0001415889-23-011251 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230714 FILED AS OF DATE: 20230718 DATE AS OF CHANGE: 20230718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilliam Joseph E CENTRAL INDEX KEY: 0001705850 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37463 FILM NUMBER: 231095480 MAIL ADDRESS: STREET 1: C/O GLAUKOS CORPORATION STREET 2: 229 AVENIDA FABRICANTE CITY: SAN CLEMENTE STATE: CA ZIP: 92677 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLAUKOS Corp CENTRAL INDEX KEY: 0001192448 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 229 AVENIDA FABRICANTE CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 949-367-9600 MAIL ADDRESS: STREET 1: 229 AVENIDA FABRICANTE CITY: SAN CLEMENTE STATE: CA ZIP: 92672 FORMER COMPANY: FORMER CONFORMED NAME: GLAUKOS CORP DATE OF NAME CHANGE: 20020925 4 1 form4-07192023_010723.xml X0508 4 2023-07-14 0001192448 GLAUKOS Corp GKOS 0001705850 Gilliam Joseph E C/O GLAUKOS CORPORATION ONE GLAUKOS WAY ALISO VIEJO CA 92656 false true false false PRESIDENT & COO 0 Common Stock 2023-07-14 4 M 0 19599 41.69 A 140083 D Common Stock 2023-07-14 4 M 0 10000 30.92 A 150083 D Common Stock 2023-07-14 4 M 0 10000 39.10 A 160083 D Common Stock 2023-07-14 4 M 0 2500 39.10 A 162583 D Common Stock 2023-07-14 4 S 0 42099 78.34 D 120484 D Stock Option (Right to Buy) 41.69 2023-07-14 4 M 0 19599 0 D 2027-05-05 Common Stock 19599 117044 D Stock Option (Right to Buy) 30.92 2023-07-14 4 M 0 10000 0 D 2028-03-14 Common Stock 10000 18437 D Stock Option (Right to Buy) 39.10 2023-07-14 4 M 0 10000 0 D 2030-03-12 Common Stock 10000 40466 D Includes 84,219 restricted stock units that have not yet vested or been delivered to the Reporting Person. This trade was made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. This option was granted on May 5, 2017 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. Diana Scherer, Attorney-in-Fact 2023-07-18